Acute renal failure in patients with sepsis

cc5735 CCJ Letter Acute renal failure in patients with sepsis Lopes António José jalopes93@hotmail.com Jorge Sofia Resina Cristina Santos Carla Pereira Álvaro Neves José Antunes Francisco Prata Martins Mateus

Department of Nephrology and Renal Transplantation, Hospital de Santa Maria, Av. Prof. Egas Moniz, 1649-035, Lisboa, Portugal

Department of Infectious Diseases, Hospital de Santa Maria, Av. Prof. Egas Moniz, 1649-035, Lisboa, Portugal

Critical Care 1364-8535 2007 11 2 411 http://ccforum.com/content/11/2/411 1746608010.1186/cc5735 19 4 2007 2007 BioMed Central Ltd

The evaluation of acute renal failure (ARF) by the newly developed classification for ARF (RIFLE, standing for 'risk, injury, failure, loss, end-stage kidney disease') 1 in patients with sepsis has not yet been performed. We evaluated, retrospectively, the incidence of ARF and its risk factors, therapy, and outcome among patients with sepsis admitted to the Infectious Diseases Intensive Care Unit of the Hospital de Santa Maria between January 2005 and December 2006. ARF was defined by means of the RIFLE classification 1. Sepsis was classified in accordance with the American College of Chest Physicians and the Society of Critical Care Medicine consensus 2. In all, 182 patients (aged 56.2 ± 18.56 years (mean ± SD), 120 male, 162 Caucasian) were analyzed. Baseline characteristics of the patients are summarized in Table 1. Sixty-eight patients (37.4%) had ARF. By multivariate analysis, age more than 60 years (odds ratio (OR) 0.39, 95% confidence interval (CI) 0.17 to 0.87, P = 0.002), male (OR 5.5, 95% CI 2.2 to 13.5, P < 0.0001), chronic kidney disease (OR 0.2, 95% CI 0.06 to 0.79, P = 0.021), Gram-negative-related infection (OR 0.38, 95% CI 0.16 to 0.89, P = 0.027), and a Simplified Acute Physiology Score, version II (SAPS II) > 50 (OR 0.14, 95% CI 0.06 to 0.31, P < 0.0001) were independently associated with ARF. Thirteen patients (3 with injury and 10 with renal failure) had received renal replacement therapy (12 receiving continuous venovenous hemodiafiltration, and 1 receiving intermittent hemodialysis). The mortality rate was 37.4%, and increased from 'normal' to 'failure'. Patients who did not die had renal function recovery. Multivariate analysis including age more than 60 years, gender, SAPS II > 50, comorbidity (namely cardiovascular disease), and ARF showed that SAPS II > 50 (OR 0.12, 95% CI 0.05 to 0.29, P < 0.0001) and ARF (OR 0.26, 95% CI 0.11 to 0.63, P = 0.003) were independent predictors of mortality.

Table 1

Baseline characteristics

Variable

No AKI

Risk

Injury

Failure

114

Age (years)^a

54 ± 18.2

61.9 ± 20.9

61.6 ± 13.4

61.8 ± 16.3

Sex (male)

65 (57)

10 (91)

18 (85.7)

27 (75)

0.009

Race (Caucasian)

102 (89.5)

10 (91)

20 (95.2)

30 (83.3)

Severe sepsis^b

77 (67.5)

6 (54.5)

12 (57.1)

13 (36.1)

0.012

Septic shock^b

25 (21.9)

4 (36.4)

8 (38)

23 (64)

<0.0001

CVD

37 (32.4)

3 (27.3)

10 (47.6)

14 (38.9)

CKD

5 (43.9)

1 (9)

4 (19)

8 (22.2)

0.009

SAPS II > 50

22 (19.3)

6 (54.5)

7 (33.3)

9 (26.5)

0.06

Mortality

11 (9.6)

3 (27.3)

6 (28.6)

20 (55)

<0.0001

Figures in parentheses are percentages. AKI, acute kidney injury; CKD, chronic kidney disease; CVD, cardiovascular disease, diabetes mellitus and hypertension; NS, not significant; SAPS II, Simplified Acute Physiology Score, version II. The SAPS II was calculated on the basis of the worst variables recorded during the first 24 hours of ICU admission. ^aMeans ± SD; ^bsepsis was classified in accordance with American College of Chest Physicians and the Society of Critical Care Medicine consensus [2].

Thus, ARF as determined by RIFLE is common among patients with sepsis, and increases mortality. Age, gender, chronic kidney disease, Gram-negative-related infection and severity of illness are independently associated with ARF in this setting.

Abbreviations

ARF = acute renal failure; CI = confidence interval; OR = odds ratio; RIFLE = risk, injury, failure, loss, end-stage kidney disease; SAPS II = Simplified Acute Physiology Score, version II.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

JAL, SJ, CR, and CS made substantial contributions to the conception and design of the study, to the acquisition of data, and to the analysis and interpretation of data. JAL, CR, AP, JN, FA, and MMP were involved in drafting the manuscript and revising it critically for important intellectual content. All authors read and approved the final manuscript.

Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group Bellomo R Ronco C Kellum JA Mehta RL Palevsky P the ADQI workgroup Crit Care 2004 8 R204 R212 522841 15312219 10.1186/cc2872 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Levy MM Fink MP Marshall JC Abraham E Angus D Cook D Cohen J Opal SM Vincent JL Ramsay G SCCM/ESICM/ACCP/ATS/SIS Crit Care Med 2003 31 1250 1256 12682500 10.1097/01.CCM.0000050454.01978.3B